Cargando…
Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918487/ https://www.ncbi.nlm.nih.gov/pubmed/31897090 http://dx.doi.org/10.1177/1758835919887667 |
| _version_ | 1783480601367543808 |
|---|---|
| author | Glas, Martin Kebir, Sied |
| author_facet | Glas, Martin Kebir, Sied |
| author_sort | Glas, Martin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6918487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69184872020-01-02 Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? Glas, Martin Kebir, Sied Ther Adv Med Oncol Letter to the Editor SAGE Publications 2019-12-16 /pmc/articles/PMC6918487/ /pubmed/31897090 http://dx.doi.org/10.1177/1758835919887667 Text en © The Author(s), 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Glas, Martin Kebir, Sied Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title | Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title_full | Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title_fullStr | Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title_full_unstemmed | Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title_short | Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| title_sort | regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918487/ https://www.ncbi.nlm.nih.gov/pubmed/31897090 http://dx.doi.org/10.1177/1758835919887667 |
| work_keys_str_mv | AT glasmartin regorafenibinglioblastomarecurrencehowtodealwithconflictingreallifeexperiences AT kebirsied regorafenibinglioblastomarecurrencehowtodealwithconflictingreallifeexperiences |